¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"internal ribosomal entry site"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • internal cerebral veins
    ¼Ó´ë³úÁ¤¸Æ, ³»´ë³úÁ¤¸Æ
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conjugate diameter
    ¼Ó¾ÕµÚÁö¸§, ³»°áÇÕ°æ
  • internal conversion
    ³»ºÎº¯È¯
  • internal decompression
    ³»°¨¾Ð(¼ú)
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤(¹ý)
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»´©°ø
  • internal fixation
    ³»(ºÎ)°íÁ¤
  • internal genu
    ¿Ü¹Ý½½, ¹Û±ÁÀ̹«¸­
  • internal hemorrhoid
    ³»Ä¡ÇÙ
  • internal hordeolum
    ¼Ó´Ù·¡³¢
  • internal iliac artery
    ¼Ó¾ûµ¢µ¿¸Æ, ³»Àå°ñµ¿¸Æ
  • internal iliac vein
    ¼Ó¾ûµ¢Á¤¸Æ, ³»Àå°ñÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • internal barotrauma
    ³»Àξз¼ջó
  • internal bleeding
    ³»ÃâÇ÷
  • internal callus
    (¢¡central callus) Á߽ɾֹú»À
  • internal capsule
    ¼Ó¼¶À¯¸·
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conversion
    ³»ºÎº¯È¯
  • internal acoustic canal
    ¼Ó±Ó±æ, ³»À̵µ
  • internal decompression
    ³»°¨¾Ð¼ú
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤
  • internal conjugate diameter
    ¾ÈÂʾյÚÁö¸§, ³»°áÇÕ°æ
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal environment
    ³»ºÎȯ°æ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»·ç
  • internal genu
    (¢¡genu valgum) ¿Ü¹Ý½½, ¾È±ÁÀ̹«¸­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • artery, internal maxillary
    ³»»ó¾Çµ¿¸Æ
  • fundus of internal acoustic meatus
    ¼Ó±Í±æ¹Ù´Ú
  • genu of internal capsule
    ¼Ó¼¶À¯¸·¹«¸­
  • inner ear =internal e.
    ³»ÀÌ
  • inner ear =internal e.
    ³»ÀÌ(Ò®ì¼).
  • inner language =internal speech
    ³»¾ð¾î
  • posterior internal vertebral venous plexus
    µÚ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • posterior limb of internal capsule
    ¼Ó¼¶À¯¸·µÚ´Ù¸®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • packaging site
    ²Ù¸®±âºÎÀ§
  • placental site trophoblastic tumor
    ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
  • privileged site
    Ưº°°Ý¸®ºÎÀ§
  • receptor site
    ¼ö¿ëüºÎÀ§.
  • variations of site
    À§Ä¡º¯ÀÌ
  • web site
    À¥ ½ÎÀÌÆ®
  • aberrant internal carotid artery
    À̻󳻰浿¸Æ
  • anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
  • anterior limb of internal capsule
    ¼Ó¼¶À¯¸·¾Õ´Ù¸®
  • apparatus internal compliance
    ±â°è³»Åº¼º.
  • artery, internal maxillary
    ³»»ó¾Çµ¿¸Æ
  • band of internal granular layer
    ¼Ó°ú¸³Ãþ¼¶À¯ÁÙ
  • band of internal pyramidal layer
    ¼ÓÇǶó¹ÔÃþ¼¶À¯ÁÙ
  • branches of internal capsule
    ¼Ó¼¶À¯¸·°¡Áö
  • bronchial branches of internal thoracic artery
    ³»Èä°ûµ¿¸ÆÀÇ ±â°üÁö(µ¿¸Æ)Áö.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Internal carotid artery
    ¼Ó¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ
  • Internal carotid nerve
    ¼Ó¸ñ½Å°æ
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ½Å°æ
  • Internal carotid plexus
    ¼Ó¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ³»°æµ¿¸Æ½Å°æÃÑ
  • Internal jugular vein
    ¼Ó¸ñÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»°æÁ¤¸Æ
  • Internal carotid venous plexus
    ¼Ó¸ñÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] °æµ¿¸Æ°üÁ¤¸ÆÃÑ
  • Internal wall
    ¼Óº®
    [¿¾ ¿ë¾î] ³»º®
  • Internal part
    ¼ÓºÎºÐ
    [¿¾ ¿ë¾î] ³»ÃøºÎ
  • Internal enamel epithelium
    ¼Ó»ç±âÁú»óÇÇ
    [¿¾ ¿ë¾î] ³»¿¡³ª¸á»óÇÇ
  • Internal mitochondrial membrane
    ¼Ó»ç¸³Ã¼¸·
    [¿¾ ¿ë¾î] »ç¸³Ã¼³»¸·
  • Internal capsule
    ¼Ó¼¶À¯¸·
    [¿¾ ¿ë¾î] ³»Æ÷
  • Branches of internal capsule
    ¼Ó¼¶À¯¸·°¡Áö
    [¿¾ ¿ë¾î] ³»Æ÷Áö
  • Posterior limb of internal capsule
    ¼Ó¼¶À¯¸·µÚ´Ù¸®
    [¿¾ ¿ë¾î] ³»Æ÷Èİ¢
  • Genu of internal capsule
    ¼Ó¼¶À¯¸·¹«¸­
    [¿¾ ¿ë¾î] ³»Æ÷½½
  • Anterior limb of internal capsule
    ¼Ó¼¶À¯¸·¾Õ´Ù¸®
    [¿¾ ¿ë¾î] ³»Æ÷Àü°¢
  • Internal medullary lamina
    ¼Ó¼¶À¯ÆÇ
    [¿¾ ¿ë¾î] ³»¼öÆÇ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • alternate-site model
    ±³´ëºÎÀ§(ÎßÓÛÝ»êÈ)¸ðÅÚ
  • amino acid attachement site
    ¾Æ¹Ì³ë»ê(ß«) ºÎÂø(ݾó·)ÀÚ¸®
  • aminoacyl site
    ¾Æ¹Ì³ë¾Æ½Ç ÀÚ¸®
  • aminoacyl-tRNA site
    ¾Æ¹Ì³ë¾Æ½ÇtRNA ÀÚ¸®
  • antibody combining site
    Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
  • antigen binding site
    Ç׿ø°áÇÕ(ù÷ê«Ì¿ùê)ÀÚ¸®
  • AP site
    AP ÀÚ¸®
  • A-site
    AÀÚ¸®
  • attachment site
    ºÎÂø(ݾó·)ÀÚ¸®
  • binding site
    °áÇÕ(Ì¿ùê)ÀÚ¸®
  • catalytic site
    Ã˸Å(õºØÚ)ÀÚ¸®
  • codon recognizing site
    ÄÚµ· ÀνÄ(ìããÛ) ÀÚ¸®
  • combining site
    °áÂø(Ì¿ó·)ÀÚ¸®
  • condensing site
    ÃàÇÕ(õêùê)ÀÚ¸®
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • permissible internal dose
    ³»ºÎÇã¿ë¼±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IR drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat...
AE above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers...
AOE admission order entry
CEB calcium entry blocker
DREZ dorsal root entry zone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ARDRA Amplified ribosomal DNA restriction analysis
NRPS non-ribosomal peptide synthetase
r Ribosomal
rDNA Ribosomal DNA
rRNA Ribosomal RNA
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • internal echo
    ³»ºÎ ¿¡ÄÚ
  • internal environment
    ³»ºÎ ȯ°æ
  • internal fixation
    ³»ºÎ °íÁ¤
  • internal focusing
    ³»ºÎ ÃÊÁ¡ Á¶Àý
  • internal granuloma
    ¾Ç°ñ³» À°¾ÆÁ¾
  • internal hemorrhoid
    ³»Ä¡ÇÙ
  • internal iliac artery
    ³»Àå°ñ µ¿¸Æ
  • internal irradiation
    ü³» Á¶»ç, ³»ºÎ Á¶»ç
  • internal jugular vein
    ³»°æÁ¤¸Æ
  • internal mammary artery
    ³»À¯¹æ µ¿¸Æ
  • internal medicine
    ³»°ú, ³»°úÇÐ
    ÀϹÝÀûÀ¸·Î ³»Àå¿¡ ¿øÀÎÀÌ ÀÖ´Â ÁúȯÀ» ´Ù·ç´Â ÀÓ»ó ÀÇÇÐ. ¾ö¹ÐÇÑ Á¤ÀǸ¦ ³»¸®±â´Â ¾î·ÆÁö¸¸ 15¼¼ ÀÌ»ó »ç¶÷ÀÇ °¢Á¾ Áúº´À» Áø´ÜÇÏ¸ç ¼ö¼úÀû ¿ä¹ýÀ» »ç¿ëÇÏÁö ¾Ê°í ¾à¹° Ä¡·á¸¦ ÇÏ´Â ºÎ¹®À» ¸»ÇÑ´Ù. ³»°ú¿¡¼­ ´Ù·ç´Â Áúº´À» ºÐ·ùÇÏ¸é °¨¿°Áõ, ¼øÈ¯±â Áúȯ, ½Å°æ°è Áúȯ, ¼ÒÈ­±â°è Áúȯ, Ç÷¾× Áúȯ, È£Èí±â Áúȯ, ³»ºÐºñ¼± Áúȯ, ºñ´¢±â Áúȯ, ¾Ë·¹¸£±â¼º Áúȯ, ½ÅÁø´ë»ç Áúȯ, ±³¿øº´, Áßµ¶ µî ¸Å¿ì ¹üÀ§°¡ ³Ð´Ù. ¿ª»çÀûÀ¸·Î º¸¸é ³»°úÇÐÀÌ Çй®À¸·Î¼­ ¹ßÀüÇÑ °ÍÀº »ý¸®ÇÐ, ÇØºÎÇÐÀÌ ¹ß´ÞÇÑ 16~17¼¼±âÀÇ ÀÏÀÌ´Ù. 18¼¼±â¿¡ ü¿Â°è¸¦ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ ¹ß´ÞÇϰí ŸÁø¹ýÀÌ ¹ß¸íµÇ¾úÀ¸¸ç, 19¼¼±â¿¡´Â ûÁø±â°¡ ¹ß¸íµÊ¿¡ µû¶ó ´õ¿í Áøº¸ÇÏ¿´´Ù. 19¼¼±â ÈĹÝÀÇ X¼± ¹ß°ß°ú µ¶ÀÏÀÇ R. ÄÚÈå¿Í ÇÁ¶û½ºÀÇ L. ÆÄ½ºÅ𸣠µî¿¡ ÀÇÇÑ ¼¼±ÕÇÐÀÌ È®¸³µÊÀ¸·Î½á ³»°úÇÐÀº ºñ¾àÀûÀ¸·Î ¹ßÀüÇÏ¿´´Ù. ±Ù³â¿¡´Â Áúȯº°, Àå±âº°·Î Àü¹® ºÐ¾ß°¡ µ¶¸³, ºÐ°úÇÏ´Â °æÇâÀÌ ÀÖ´Ù. ¿¹¸¦ µé¸é, ¼øÈ¯±â°ú, ¼ÒÈ­±â°ú, Ç÷¾×°ú µîÀÌ´Ù.
  • internal oblique ridge
    ³»»ç¼±
  • internal obturator muscle
    ³»Æó¼â±Ù
  • internal occipital protuberance
    ³»ÈĵΠÀ¶±â
  • internal poroity
    ³»ºÎ ±âÆ÷
    ¼öÁö¸¦ ÀÌ¿ëÇÏ¿© ÀÇÄ¡»ó Á¦ÀÛ ½Ã ¿Â¼º °úÁ¤¿¡¼­ ¹ß»ýÇÏ´Â ÀÇÄ¡»ó ³»ºÎÀÇ ±âÆ÷·Î¼­ ±× Á¾·ù´Â ´Ù¾çÇÏ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
apurinic site <molecular biology> Sites in DNA from which purines have been lost by cleavage of the deoxy ribose N glycosidic linkage.
(18 Nov 1997)
apyrimidinic site <molecular biology> A site on DNA where a base is missing, in this case a pyrimidine (either cytosine or thymine), but the phosphodiester backbone is still intact.
Compare: apurinic site.
(09 Oct 1997)
ATT site <molecular biology> A site on the chromosome of the bacteria E. Coli where the lambda bacteriophage can insert its genome (all of its DNA) so that it can lie dormant and have its DNA reproduced whenever the bacterium reproduces for as long as the bacterium remains healthy (that is, so that it becomes lysogenic).
(09 Oct 1997)
gaylus-site <chemical> A yellowish white, translucent mineral, consisting of the carbonates of lime and soda, with water.
Origin: Named after Gay-Lussac, the French chemist.
(20 Mar 1998)
receptor site Point of attachment of viruses, hormones, or other activators to cell membranes.
(05 Mar 2000)
catalytic site <chemistry> The site on an enzyme where the substrate or substrates (the reactants of a chemical or biochemical reaction) attach in order to convert to the product or products of the reaction, at a much higher speed than the substrate would need to convert to the product alone.
(16 Mar 1998)
replication site The in vivo site on DNA of DNA replication.
(05 Mar 2000)
restriction enzyme cutting site <molecular biology> A specific nucleotide sequence of DNA at which a particular restriction enzyme cuts the DNA.
Some sites occur frequently in DNA (for example, every several hundred basepairs), others much less frequently (rare-cutter, for example, every 10,000 base pairs).
(10 Mar 1998)
restriction site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
restriction-site polymorphism DNA polymorphism in which the sequence of one form of the polymorphism contains a recognition site for a particular endonuclease, but the sequence of the other form lacks such a site.
(05 Mar 2000)
chi site <molecular biology> Short, active sequences of DNA which strongly encourages crossing over of chromosomes to occur at that site. These sites become chiasmata more often than other sites.
(05 Jan 1998)
ribosome binding site The region of a messenger RNA molecule that binds the ribosome to initiate translation.
(09 Oct 1997)
cleavage site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
combining site <biochemistry, immunology> Any region of a molecule that binds or reacts with a given compound. Especially of the region of immunoglobulin that combines with the determinant of an appropriate antigen.
(09 Jan 1998)
placental site trophoblastic tumour A tumour usually arising in the uterus of parous women during reproductive years. Histologically, the tumour consists of a predominance of intermediate trophoblastic cells with fibrinoid material and vascular invasion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á